AG​ Bonta joined a coalition of AGs in submitting amicus briefs opposing demands from the Federal Trade Commission (FTC) seeking documentation on clinical guidance published by the Endocrine Society and the World Professional Association for Transgender Health (WPATH) regarding gender-affirming care. In the brief, Attorney General Bonta and the coalition argue that the FTC’s demands are an improper effort to target reputable scientific organizations whose work is pivotal to states’ efforts to promote their populations’ health.

“The Federal Trade Commission is again making unreasonable demands in an effort to undermine evidence-backed healthcare guidance. We will not allow transgender Americans nor the healthcare providers they trust to lose access to crucial resources simply because the FTC dislikes those resources’ contents. We will continue to protect the health of our communities and oppose the Trump Administration’s improper attempts to advance its anti-transgender agenda.” – AG Bonta